Please use this identifier to cite or link to this item:
|Title:||Detection of low level nilotinib or dasatinib resistant BCR-ABL mutations by mass spectrometry in CML patients who fail Imatinib is highly predivtive of their subsequent clonal expansion when treated with the drug for which their mutation confers resistance|
|Citation:||Proceedings of 2010 american society of hematology meeting, 2010|
|Publisher:||AMER SOC HEMATOLOGY|
|Conference Name:||American Society of Hematology Meeting (52nd : 2010 : Florida, CA.)|
|Wendy T Parker, Musei Ho, Rebecca M Lawrence, Darryl L Irwin, Hamish S Scott, Timothy Hughes and Susan Branford|
|Rights:||Copyright status unknown|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.